Improving sleep and physical activity for African American adults with obesity
Project SHINE (Sleep Health INitiative for Equity): Culturally Informing a Sleep Extension Intervention for African American Adults
This study is testing a program to help African American adults with obesity get better sleep and be more active to see if it can improve their health.
Quick facts
| Phase | Phase1; Phase2 |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 21 Years to 75 Years |
| Sex | All |
| Sponsor | University of Minnesota Academic / other |
| Locations | 1 site (Minneapolis, Minnesota) |
| Trial ID | NCT06226077 on ClinicalTrials.gov |
What this trial studies
This research aims to address obesity-related health disparities by promoting healthy lifestyle behaviors among African American adults. The study consists of two phases: Phase 1 involves qualitative interviews to understand social factors affecting sleep and gather feedback on a sleep intervention, while Phase 2 is a randomized clinical trial assessing the feasibility and effectiveness of a sleep extension intervention. Participants will be sedentary and short sleepers, with a focus on increasing their sleep duration and physical activity levels.
Who should consider this trial
Good fit: Ideal candidates are African American adults aged 21 to 75 years, with a body mass index of 25 or higher and who report sleeping 6 hours or less per night.
Not a fit: Patients with organ-related disorders or those who are pregnant or have an infant under one year old may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could lead to improved sleep quality and reduced obesity rates among African American adults.
How similar studies have performed: Other studies have shown promise in addressing sleep and obesity in similar populations, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Phase 1: * Not meeting Physical Activity Guidelines * age range: 21 to 75 years * body mass index: ≥25.0 kg/m2 * average self-reported habitual sleep duration of ≤6 hours * self-identify as Black or African American Phase 2: * Not meeting Physical Activity Guidelines * age range: 21 to 75 years * body mass index: ≥25.0 kg/m2 * average self-reported habitual sleep duration of ≤6 hours * self-identify as Black or African American Exclusion Criteria: Phase 1: * Self-reported organ-related disorder (COPD, cardiac arrhythmia, gastro-esophageal disorder) * pregnant or less than 4 months postpartum * infant living in household less than 1 year old Phase 2: * Self-reported organ-related disorder (COPD, cardiac arrhythmia, gastro-esophageal disorder) * pregnant or less than 4 months postpartum * infant living in household less than 1 year old
Where this trial is running
Minneapolis, Minnesota
- University of Minnesota — Minneapolis, Minnesota, United States (Recruiting)
Study contacts
- Principal investigator: Ivan Wu, PhD — University of Minnesota
- Study coordinator: Rachel Price, MPH
- Email: price919@umn.edu
- Phone: 612-624-2254
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.